BACK TO TOP

90

FDA Approves CAR T Therapy for Large B-Cell Lymphoma Developed at University of Pennsylvania

DietarySupplements (#1) 457 days ago Health fda approves car therapy large b-cell lymphoma developed university pennsylvania All http://www.newswise.com   Discuss  | Add To 
The U.S. Food and Drug Administration (FDA) has expanded approval for a personalized cellular therapy developed at the University of Pennsylvania's Abramson Cancer Center, this time for the treatment of adult patients with relapsed or refractory large B-Cell lymphoma after two or more lines of systemic therapy. Today's approval includes treatment of diffuse large B-cell lymphoma (DLBCL) - the most common form of non-Hodgkin's lymphoma - as well as high grade B-cell lymphoma and DLBCL arising from follicular lymphoma.

Dietary Supplement & Health Search Engine

Dietary Supplement Reviews from users worldwide. Get up to date dietary supplement information from name brand dietary supplement makers at DietarySupplement.com








Featured Supplements

Advertise With Us!